CSI Market
Sign In | Register

Kymera Therapeutics Inc (KYMR) Annual Balance Sheets

Annual · GAAP · USD millions
Access KYMR quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Kymera Therapeutics Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent357.01
Combined Cash+Investments Total (filer-reported)1,619.40
Available-for-sale Securities, Debt Securities, Current MA491.27
Short-term Investments0.00
Cash & Short-term Investments848.00
Accounts receivable0.00
Due from Related Parties, Current RE0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current22.94
Total Current Assets871.21
Equipment/Property/Plant Net43.18
Long-term investments771.16
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent828.42
Contract With Customer Asset Net Current-
Operating Lease Right Of Use Asset42.35
Restricted Cash Noncurrent5.80
Total Assets1,742.81
Liabilities
Accounts Payable, Current AC4.02
Accrued Liabilities, Current AC42.27
Other Liabilities, Current0.24
Total Current Liabilities83.21
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Contract With Customer Liability Current22.93
Operating Lease Liability Current11.94
Finance Lease Liability Current1.82
Contract With Customer Liability Noncurrent11.44
Operating Lease Liability Noncurrent67.03
Finance Lease Liability Noncurrent1.46
Total Liabilities163.15
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock2,643.82
Retained Earnings / Accumulated Deficit-1,065.96
Accumulated Other Comprehensive Income0.00
Other Equity1.80
Common Stockholder's Equity1,579.66
Total Stockholder's Equity1,579.66
Liabilities & Stockholder's Equity1,742.81
4 historic quarters locked

Sign in to unlock the full Kymera Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Kymera Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: kymr-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-073395

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License